May 7, 2020 / 9:21 PM / 2 months ago

BRIEF-Sage Therapeutics Announces First Quarter 2020 Financial Results

May 7 (Reuters) - SAGE Therapeutics Inc:

* SAGE THERAPEUTICS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND HIGHLIGHTS PIPELINE AND BUSINESS PROGRESS

* Q1 REVENUE $2.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $2.8 MILLION

* SAGE THERAPEUTICS - SEES CASH BALANCE OF AT LEAST $550 MILLION AT END OF 2020, WHICH CO SEES TO SUPPORT OPERATIONS INTO 2022 BASED ON CURRENT OPERATING PLANS

* QTRLY LOSS PER SHARE $2.44 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below